Reduced Cost Blood Factor Production - Model Molecule, Protein C
Reduced Cost Blood Factor Production - Model Molecule, Protein C
批准号:
0090749
负责人:
Duane Bruley
金额:
$18.25万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-15 至 2005-08-31
中文摘要
本研究是美国红十字会和马里兰大学巴尔的摩县分校联合开展的一项研究,旨在研究固定化金属亲和层析(IMAC)作为一种替代免疫亲和层析分离高分子量同源血因子的方法。感兴趣的来源材料是血浆Cohn组分1V-1,它是包括维生素K依赖蛋白(VKD)在内的血液蛋白的复杂混合物,VKD是确保止血所必需的。通过NSF-SGER赠款进行的初步研究证实,IMAC是一种高度选择性的分离技术,可能能够在制备性规模上实现所需的分离。IMac的机制包括使用适当的金属离子/螯合剂组合,这些组合对血液中出现的特定氨基酸具有亲和力。证据表明,当使用适当的缓冲液时,将iMac底物与生物分子组氨酸单元的数量和位置相匹配可以导致有效的分离。这项研究项目包括研究一些关键的VKD血液蛋白的表面组氨酸浓度,确定蛋白C在选定的IMAC柱上的平衡等温线,以及使用实验设计技术来确定最佳的色谱操作条件,以便为获奖后的动物研究分离毫克量的蛋白C。迫切需要以低成本大量生产各种人类血液因子用于治疗应用。血液因素以一种非常复杂的方式联系在一起,因此在正常情况下,血液会凝结起来止血。当凝血剂和抗凝剂失衡时,可能会出现两种病理状态:(A)患者是血友病患者,或(B)患者是血栓患者。我们的模型血液因子是蛋白C,它是人类凝血级联反应中关键的抗凝剂。蛋白C缺乏可导致深静脉血栓形成(DVT),并有可能出现肺血栓,这是威胁患者生命的并发症。应该指出的是,异常凝血障碍是导致死亡的主要原因,仅次于艾滋病和癌症。目前使用肝素或香豆素的治疗方法是有效的,但可能会有危险的副作用。大量、低成本的蛋白C产品可以为蛋白C缺乏症患者提供廉价、安全的治疗。
英文摘要
AbstractREDUCED COST BLOOD FACTOR PRODUCTION -MODEL MOLECULE, PROTEIN CDuane F. Bruley University of Maryland Baltimore CountyNSF Proposal Number 0090749 This research is a joint effort between The American Red Cross(ARC) and the University of Maryland Baltimore County(UMBC) to study Immobilized Metal Affinity Chromatography(IMAC) as an alternative process to replace Immuno Affinity Chromatography for the separation of high-molecular-weight, homologous blood factors. The source material of interest is blood plasma Cohn Fraction 1V-1, which is a complex mixture of blood proteins including the Vitamin K Dependent Proteins (VKD) that are essential to insure blood hemostasis. Initial studies via an NSF-SGER grant verified that IMAC is a highly selective separation technology that might be able to achieve the desired separations on a preparative scale. The mechanism of IMAC includes the use of appropriate metal ion/chelating agent combinations that have affinity for specific amino acids that occur in blood. Evidence shows that matching the IMAC substrate with the number and the placement of biomolecule histidine units can lead to efficient separations when the appropriate buffers are used. This research project includes investigations of the surface histidine concentration on some of the critical VKD blood proteins, the determination of equilibrium isotherms for Protein C on selected IMAC columns, and the use of experimental-design techniques to determine optimal chromatographic operating conditions that will allow the separation of milligram quantities of Protein C for post-award animal studies.There is an urgent need for the production of a variety of human blood factors in large quantities at low cost for therapeutic applications . The blood factors are linked together in a very complex way so that under normal conditions the blood will clot to stop bleeding. When an imbalance of coagulants and anti-coagulants occurs, two pathologic states can develop: (a) the patient is a hemophilic, or (b) the patient is a clotter.Our model blood factor is Protein C, which is the pivotal anti-coagulant in the human coagulation cascade. Protein C deficiency can result in deep vein thrombosis (DVT) with the possibility of pulmonary embolus ,which is a life-threatening complication for the patient. It should be noted that abnormal clotting disorders are the leading cause of death, over AIDS and cancer. Present treatments with Heparin or Coumadin are effective but with dangerous side effects possible. High-volume, low-cost Protein C products could provide inexpensive, safe treatment for patients with Protein C deficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SGER: Separation and Purification of High Molecular Weight Homologous Blood Proteins using IMAC
-
批准号:9904465
-
项目类别:Standard Grant
-
资助金额:$3.0万
-
财政年份:1999
-
负责人:Duane Bruley
-
依托单位:
国内基金
海外基金
COST1通过P小体调控植物渗透胁迫响应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:许亢
-
依托单位:
COST1蛋白动态在调控自噬及植物抗旱中的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:包岩
-
依托单位:
电渣重熔625℃超超临界汽轮机转子用钢COST-FB2冶金学基础研究
-
批准号:51974076
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:耿鑫
-
依托单位: